Biosynthesis of serotonergic Kanna alkaloids

Plants have repeatedly evolved to synthesize natural products that exploit serotonin signaling in animals. Although serotonin and most of its neuroactive analogs derive from tryptophan, the medicinal Kanna plant (Mesembryanthemum tortuosum) instead uses tyrosine and phenylalanine to construct a serotonin-like scaffold through unknown chemical transformations. Here, we elucidate the biosynthesis of Kanna alkaloids, including the serotonin reuptake inhibitor mesembrine. We reveal an unusual scaffold-forming strategy that is mediated by non-canonical transferase and oxidase enzymes, and we provide mechanistic insight on how an activated biosynthetic intermediate undergoes a multistep cyclization cascade to form the Kanna alkaloid scaffold. Collectively, our work uncovers how plants repurpose unconventional metabolic building blocks and enzymes to produce serotonergic molecules with promise as therapeutics for neurological disorders.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-17
DOI
https://doi.org/10.64898/2026.11.13.766392
Primary Topic
Plant biochemistry and biosynthesis
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Biosynthesis of serotonergic Kanna alkaloids

Colin Y. Kim, Ryan S. Nett
1 links
bioRxiv (Cold Spring Harbor Laboratory)
Plant biochemistry and biosynthesis
preprint

Biosynthesis of serotonergic Kanna alkaloids

Colin Y. Kim, Ryan S. Nett
preprint en

Abstract

Plants have repeatedly evolved to synthesize natural products that exploit serotonin signaling in animals. Although serotonin and most of its neuroactive analogs derive from tryptophan, the medicinal Kanna plant (Mesembryanthemum tortuosum) instead uses tyrosine and phenylalanine to construct a serotonin-like scaffold through unknown chemical transformations. Here, we elucidate the biosynthesis of Kanna alkaloids, including the serotonin reuptake inhibitor mesembrine. We reveal an unusual scaffold-forming strategy that is mediated by non-canonical transferase and oxidase enzymes, and we provide mechanistic insight on how an activated biosynthetic intermediate undergoes a multistep cyclization cascade to form the Kanna alkaloid scaffold. Collectively, our work uncovers how plants repurpose unconventional metabolic building blocks and enzymes to produce serotonergic molecules with promise as therapeutics for neurological disorders.

bioRxiv (Cold Spring Harbor Laboratory)
Harvard University (US)
National Science Foundation, Harvard University, Korea Advanced Institute of Science and Technology, National Institutes of Health
Plant biochemistry and biosynthesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon